CPT 87389: HIV Antigen and Antibody Screening Immunoassay
Commercial payers pay $30 on average nationally for this procedure.
CPT code 87389 describes a laboratory HIV screening immunoassay that detects HIV‑1 antigen and HIV‑1/HIV‑2 antibodies and reports a single combined result; service type: infectious disease serology screening; typical site of service: clinical laboratory or hospital lab performing blood-based immunoassay testing.
Customize your policy alerts
Sign up for cpt 87389 policy alerts
Get alerted when payer policies referencing 87389 are released or updated.
Monitor payer policy activity
National Reimbursement Benchmarks
National commercial reimbursement for CPT 87389 centers on a BUCA average commercial rate of $30.4, with individual payers showing meaningful spread. Blue Cross Blue Shield (BCBS) and Aetna have higher mean rates at $34.4 and $27.9 respectively, while Cigna and UnitedHealth Group trend lower on mean and median measures; Cigna’s mean is $27.2 and UnitedHealth Group’s mean is $20.5. BUCA’s quartiles (P25 $18.1, P75 $34.2) position it near the market midpoint.
Dispersion varies notably: Blue Cross Blue Shield exhibits a range (P75−P25) of $14.5, while Aetna’s interquartile range is $13.3, and BUCA’s is $16.1. Cigna’s IQR is $20.1 and UnitedHealth Group’s is $13.5, so Cigna shows the widest IQR-driven variability and Aetna the tightest among the listed payers.